Challenges in Application
The choice of a viral vector to deliver genetic material to cells comes with some logistical problems. There are a limited number of viral vectors available for therapeutic use. Any of these few viral vectors can cause the body to develop an immune response if the vector is seen as a foreign invader. Once used, the viral vector cannot be effectively used in the patient again because it will be recognized by the body. If the vaccine or gene therapy fails in clinical trials, the virus can’t be used again in the patient for a different vaccine or gene therapy in the future. Pre-existing immunity against the viral vector could also be present in the patient rendering the therapy ineffective for that patient. It is possible to counteract pre-existing immunity when using a viral vector for vaccination by priming with a non-viral DNA vaccine, but this method presents another expense and obstacle in the vaccine distribution process. Pre-existing immunity may also be challenged by increasing vaccine dose or changing the vaccination route.
Read more about this topic: Viral Vector
Famous quotes containing the words challenges and/or application:
“A powerful idea communicates some of its strength to him who challenges it.”
—Marcel Proust (1871–1922)
“I think that a young state, like a young virgin, should modestly stay at home, and wait the application of suitors for an alliance with her; and not run about offering her amity to all the world; and hazarding their refusal.... Our virgin is a jolly one; and tho at present not very rich, will in time be a great fortune, and where she has a favorable predisposition, it seems to me well worth cultivating.”
—Benjamin Franklin (1706–1790)